The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and 380,000 deaths worldwide per annum, and account for over 10,000 annual deaths in the United States alone. Improvement in outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Ezra E. W., Bell, R. Bryan, Bifulco, Carlo B., Burtness, Barbara, Gillison, Maura L., Harrington, Kevin J., Le, Quynh-Thu, Lee, Nancy Y., Leidner, Rom, Lewis, Rebecca L., Licitra, Lisa, Mehanna, Hisham, Mell, Loren K., Raben, Adam, Sikora, Andrew G., Uppaluri, Ravindra, Whitworth, Fernanda, Zandberg, Dan P., Ferris, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6632213/
https://www.ncbi.nlm.nih.gov/pubmed/31307547
http://dx.doi.org/10.1186/s40425-019-0662-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6632213/
https://www.ncbi.nlm.nih.gov/pubmed/31307547
http://dx.doi.org/10.1186/s40425-019-0662-5

Ejemplares similares